Skip to main content

GenScript Raises $1 Billion in Investments from Hillhouse Capital

GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the investments, GenScript had a market capitalization of $6 billion and Legend was worth $4 billion. GenScript's original business unit, the Life Science Group, (now one of four businesses) offers proprietary gene synthesis technology to researchers with a global market share of 30%. More details.... Stock Symbols: (HK: 1548) (NSDQ: LEGN) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.